Article content
NEW DELHI Experts at India’s drug regulator were meeting on Wednesday to consider approving an AstraZeneca/Oxford coronavirus vaccine for emergency use after Britain became the first country to do so, two sources with knowledge of the matter said.
A representative of India’s Central Drugs Standard Control Organization (CDSCO) declined to reveal the agenda of the meeting but said its minutes would be uploaded on its website within hours.
We apologize, but this video has failed to load.
Try refreshing your browser, or India drug regulator meets to discuss AstraZeneca vaccine -sources Back to video
Sources earlier told Reuters the CDSCO was likely to approve the vaccine this week after its local manufacturer, Serum Institute of India (SII), submitted additional trial data.
World News: India likely to approve AstraZeneca vaccine by next week gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.
Government likely to approve Oxford-AstraZeneca s covid-19 vaccine by next week: Report
FILE PHOTO: Vials with a sticker reading, COVID-19 / Coronavirus vaccine / Injection only and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
(REUTERS)
Neha Arora,
, Reuters
India has not yet signed a vaccine supply deal with any company, but SII has already stockpiled more than 50 million doses of the AstraZeneca shot and plans to make a total of 400 million doses by July
Share Via
Read Full Story
NEW DELHI :
India is likely to approve Oxford/AstraZeneca s coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities, two sources with knowledge of the matter told Reuters on Tuesday.
India Likely To Approve AstraZeneca Vaccine By Next Week Sources businessworld.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessworld.in Daily Mail and Mail on Sunday newspapers.
India is likely to approve the vaccine being developed by AstraZeneca and Oxford University for emergency use by next week after its local manufacturer submitted additional data sought by authorities, the Reuters news agency reported citing two sources with knowledge of the matter.
The approval would make India the first country to give the regulatory green light to the British drugmaker’s vaccine as the British medicine regulator continues to examine data from the vaccine’s late-stage trials.
India, the world’s biggest vaccine manufacturer, wants to start inoculating its citizens next month and is also considering emergency-use authorisation applications for vaccines made by Pfizer and local company Bharat Biotech.